Seeing Is Believing
Currently out of the existing stock ratings of Narumi Nakagiri, 2 are a BUY (33.33%), 4 are a HOLD (66.67%).
Analyst Narumi Nakagiri works at DAIWA with a stock forecast success ratio of 72.22% fulfilled within 65 days on average.
Narumi Nakagiri’s has documented 12 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PFE, Pfizer at 11-May-2023.
Analyst best performing recommendations are on PFE (PFIZER).
The best stock recommendation documented was for PFE (PFIZER) at 5/11/2023. The price target of $38 was fulfilled within 12 days with a profit of $1.87 (5.18%) receiving and performance score of 4.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
350
$80.8 (30.01%)
258
2 months 11 days ago
1/2 (50%)
$57.44 (19.63%)
325
Buy
329
$59.8 (22.21%)
300
2 months 12 days ago
6/8 (75%)
$35.42 (12.06%)
68
Buy
350
$80.8 (30.01%)
310
2 months 18 days ago
29/30 (96.67%)
$27.96 (8.68%)
508
Hold
314
$44.8 (16.64%)
272
2 months 21 days ago
8/8 (100%)
$2.98 (0.96%)
96
Buy
345
$75.8 (28.16%)
310
3 months 16 days ago
22/23 (95.65%)
$46.64 (15.63%)
610
What Year was the first public recommendation made by Narumi Nakagiri?